Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v2.4.1.9
Document And Entity Information
 9 Months Ended
Sep. 30, 2014
Nov. 10, 2014
Document Information [Line Items]    
Entity Registrant Name MEDICAL TRANSCRIPTION BILLING, CORP  
Entity Central Index Key 0001582982  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol MTBC  
Entity Common Stock, Shares Outstanding   10,999,133dei_EntityCommonStockSharesOutstanding
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description We are filing this Amendment No. 1 on Form 10-Q/A to amend and restate in their entirety the following items of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 as originally filed with the Securities and Exchange Commission on November 12, 2014 (the “Original Form 10-Q”): (i) Item 1 of Part I “Financial Information,” (ii) Item 2 of Part I, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and the certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2, and 32.1 and 32.2, and our financial statements formatted in Extensible Business Reporting Language (XBRL) in Exhibits 101. No other sections were affected, but for the convenience of the reader, this report on Form 10-Q/A restates in its entirety, as amended, our Original Form 10-Q. This report on Form 10-Q/A is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement described below. Therefore, this Form-10-Q/A should be read in conjunction with filings we have made with the SEC subsequent to November 12, 2014 including the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.  
Document Period End Date Sep. 30, 2014  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2014